Fermín Goytisolo
Corporate Officer/Principal bei PANGAEA ONCOLOGY, S.A.
Profil
Fermín Goytisolo is currently the Director of Business Development & Licensing at Pangaea Oncology SA. Prior to this, he worked as a Biotechnology Manager at Najeti Capital SA, a Partner at Metas Biotech SL, and a Licensing Manager at Esteve Pharmaceuticals S.A.
Aktive Positionen von Fermín Goytisolo
| Unternehmen | Position | Beginn |
|---|---|---|
| PANGAEA ONCOLOGY, S.A. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Fermín Goytisolo
| Unternehmen | Position | Ende |
|---|---|---|
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - |
Najeti Capital SA
 Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Corporate Officer/Principal | - |
| Metas Biotech SL | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PANGAEA ONCOLOGY, S.A. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Najeti Capital SA
Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Finance |
| Metas Biotech SL | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
